Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells

Molecular Imaging

Volumn 6, Issue 1, 2007, Pages 56-67

  Parry, Jesse J ^a   Eiblmaier, Martin ^a   Andrews, Rebecca ^a   Meyer, Laura A ^a   Higashikubo, Ryuji ^a   Anderson, Carolyn J ^a   Rogers, Buck E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODISTRIBUTION; IN VITRO ASSAYS; INTRACELLULAR PROCESSING; RADIOLABELED SOMATOSTATIN ANALOGS;

BINDING ENERGY; ENZYME KINETICS; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; TUMORS;

CELL CULTURE;

COPPER 1,4,8,11 TETRAAZACYCLOTETRADECANE N,N',N'',N''' TETRAACETIC ACID OCTREOTIDE; COPPER 1,4,8,11--TETRAAZACYCLOTETRADECANE-N,N',N'',N'''-TETRAACETIC ACID-OCTREOTIDE; DRUG DERIVATIVE; OCTREOTIDE; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CHEMISTRY; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; MOUSE; NUDE MOUSE; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; POLYMERASE CHAIN REACTION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; TISSUE DISTRIBUTION; TRANSFECTION;

EID: 34247385556     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2007.00001     Document Type: Article

References (33)

1. Warner RR, O'dorisio TM. Radiolabeled peptides in diagnosis and tumor imaging: clinical overview. Semin Nucl Med 2002;32:79-83.
2. Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 2003;24:389-427.
3. Reubi JC, Laissue J, Krenning E, Lamberts SW. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol 1992;43:27-35.
4. 111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung. J Nucl Med 2001;42:1309-15.
5. 64Cu-TETA- octreotide as PET imaging agent for patients with neuroendocrine tumors. J Nucl Med 2001;42:213-21.
6. 18F-labelled, carbohydrated analogue of octreotide. Eur J Nucl Med Mol Imaging 2003;30:117-22.
7. 3-octreotide kinetics in patents with meningiomas. J Nucl Med 2005;46:763-9.
8. 3-octreotate using a cross-bridged macrocyclic chelator. Clin Cancer Res 2004;10:8674-82.
9. 18F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography. Clin Cancer Res 2004;10:3593-606.
10. 1-octreotate: a somatostatin analogue for labeling with metal and halogen radionudides for cancer imaging and therapy. Bioconjug Chem 2002;13:721-8.
11. Bernard BF, Krenning E, Breeman WAP, et al. Use of rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy. Nucl Med Commun 2000;21:1079-85.
12. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy. Eur J Nucl Med Mol Imaging 2005;32:1288-95.
13. 3-octreotate. A new somatostatin analog with improved target tissue uptake. Nucl Med Biol 1999;26:267-73.
14. 1-octreotide in nude mice transplanted with a human carcinoid tumor. Nucl Med Biol 2001;28:67-73.
15. Vaidyanathan G, Friedman HS, Affleck DJ, et al. Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts. Clin Cancer Res 2003;9:1868-76.
16. 3-octreotate in an animal model. J Nucl Med 2004;45:1542-8.
17. Kundra V, Mannting F, Jones AG, Kassis AI. Noninvasive monitoring of somatostatin receptor subtype 2 chimeric gene transfer. J Nucl Med 2002;43:406-12.
18. Yang D, Han L, Kundra V. Exogenous gene expression in tumors: noninvasive quantification with functional and anatomic imaging in a mouse model. Radiology 2005;235:950-8.
19. Koller KJ, Whitehorn EA, Tate E, et al. A genetic method for the production of cell lines expressing high levels of 7-transmembrane receptors. Anal Biochem 1997;250:51-60.
20. Rogers BE, Chaudhuri TR, Reynolds PN, et al. Non-invasive gamma camera imaging of gene transfer using an adenoviral vector encoding an epitope tagged receptor as a reporter. Gene Ther 2003;10:105-14.
21. 64Cu using a biomedical cyclotron. Nucl Med Biol 1997;24:35-43.
22. Anderson CJ, Pajeau TS, Edwards WB, et al. In vitro and in vivo evaluation of copper-64-octreotide conjugates. J Nucl Med 1995;36:2315-25.
23. 1-octreotide to human ovarian tumor xeno grafts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. Clin Cancer Res 1999;5:383-93.
24. 125I-radiolabeled bitistatin as potential agents for targeting αv β3 integrins in tumor angiogenesis. Bioconjug Chem 2004;15:988-96.
25. 11]somatostatin-14 to human small cell lung carcinoma (NCI-H69). Life Sci 1988;43:421-7.
26. Taylor JE, Theveniau MA, Bashirzadeh R, et al. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity. Peptides 1994;15:1229-36.
27. Ginj M, Hinni K, Tschumi S, et al. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters. J Nucl Med 2005;46:2097-103.
28. 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy. J Med Chem 1999;42:1341-7.
29. Orlando C, Casini-Raggi C, Bianchi S, et al. Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue. Endocr Relat Cancer 2004;11:323-32.
30. Li M, Li W, Kim HJ, et al. Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR. J Surg Res 2004;119:130-7.
31. Wang M, Caruano AL, Lewis MR, et al. Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer. Cancer Res 2003;63:6864-9.
32. O'Halloran TV, Culotta VC. Metallochaperones, an intracellular shuttle service for metal ions. J Biol Chem 2000;275:25057-60.
33. Arnesano F, Banci L, Bertini I, et al. The unusually stable quaternary structure of human Cu,Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status. J Biol Chem 2004;279:47998-8003.